Specialized group pursues life sciences growth equity investments
SAN FRANCISCO--(BUSINESS WIRE)-- Health Evolution Partners (HEP), a manager of health care investment funds, announced today the formation of a life sciences team in the Health Evolution Partners Growth Fund. The team will focus on investments in commercial-stage life sciences companies with the potential to be market leaders in many sectors, including medical devices/products, specialty pharmaceuticals, drug delivery technologies, outsourcing, manufacturing and research.
“We see a lot of opportunity to bring our capital, expertise and network to life sciences companies that have demonstrated commercial success,” said David Brailer, MD, PhD, Chairman of Health Evolution Partners. “The life sciences team joins our services and health information technology teams in seeking out the most promising health care investment opportunities.”
Consistent with the HEP philosophy, the life sciences team will provide guidance to portfolio companies to optimize their growth and performance potential. All HEP portfolio companies have access to the Health Evolution Partners Innovation Network (HEPIN), a network of health care industry experts, policy-makers, entrepreneurs and thought leaders. HEPIN brings together deep knowledge about health care delivery, financing, products and policy for innovative health care companies.
Key members of the HEP life science team are Ned Brown, Avinash Kenkare and Joshua Saipe.
- Ned Brown was previously a Managing Director at TPG Biotech. Ned has more than 25 years of experience as a private equity investor, board member, investment banker and advisor to a broad spectrum of health care companies in all sectors of the industry.
- Avinash Kenkare previously focused on health care buyouts as a Principal at the Carlyle Group and at Avista Capital Partners LLC. He has health care investment experience with DLJ Merchant Banking Partners and Credit Suisse Private Equity and has served as an advisor to a number of medical device, diagnostic and specialty pharma companies.
- Joshua Saipe previously worked at RoundTable Healthcare Partners for over seven years. At RoundTable, he focused on principal investing in medical devices and products, specialty and generic pharmaceutical, drug delivery, and outsourced services companies. Joshua began his career as an investment banker at J.P. Morgan.
The Health Evolution Partners Growth Fund invests substantial capital in companies that are commercially proven and profitable. Investments can take the form of minority or control positions achieved through buyouts, growth capital or recapitalizations. In all cases, HEP forms close working relationships with the management teams and contributes its expertise to help build these companies’ success.
In another component of HEP's life sciences efforts, the Health Evolution Partners Spectrum Fund, an investment partnership with specialized health care funds, has made a commitment to Cowen Healthcare Royalty Partners II. Cowen Royalty manages an investment program that invests principally in commercial-stage biopharmaceutical products and companies and acquires royalty interests in end-user sales of commercial-stage, or near commercial-stage medical products, such as pharmaceuticals, biotechnology products and medical devices. Related to this investment, Cowen will participate in the Health Evolution Partners Innovation Network (HEPIN).
About Health Evolution Partners
Health Evolution Partners invests in rapidly growing companies that are commercial leaders in the health care industry. We invest in all key areas of the health economy: hospitals, managed care, pharmaceutical developers, device makers and consumer products and services. Health Evolution Partners is guided by a team of exceptional health care investors and operators. We connect our companies to a substantial network of health care innovators, policy makers and thought leaders. We bring both financial resources and mindshare to our companies. Health Evolution Partners forms close working partnerships with outstanding management teams who are building important and valuable enterprises. We align our success with our companies as they grow and prosper. For more information on Health Evolution Partners, visit www.healthevolutionpartners.com.
Media Relations for
Health Evolution Partners
Mike Iamele, 508-345-9875
KEYWORDS: United States North America California
INDUSTRY KEYWORDS: Practice Management Health Pharmaceutical General Health